Literature DB >> 17573116

Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells.

Zhenyou Jiang1, Xiaolong Tang, Rui Xiao, Lifang Jiang, Xiaoyin Chen.   

Abstract

OBJECTIVES: Hemorrhage is considered to be the primary sign of Dengue hemorrhagic fever and Dengue shock syndrome. In the present study we focused on the mechanism in the pro- and anti-coagulation after Dengue virus infection.
METHODS: The effects of Dengue virus on the expression and secretion of tissue factor, tissue factor inhibitor, thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor type-1 in human umbilical vein endothelial cells were detected in this study.
RESULTS: It was shown that Dengue virus could promote the expression of thrombomodulin in cultured human umbilical vein endothelial cells, thus increasing anticoagulation, and enhancing tissue plasminogen activator activity and therefore increased hemorrhage risk.
CONCLUSIONS: The changes above may play an important role in the development of Dengue hemorrhagic fever and Dengue shock syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573116     DOI: 10.1016/j.jinf.2007.04.351

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  13 in total

Review 1.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

2.  The envelope glycoprotein domain III of Dengue virus type 2 induced the expression of anticoagulant molecules in endothelial cells.

Authors:  Lien-Cheng Chen; Trai-Ming Yeh; Yi-Ying Lin; Yi-Fen Wang; Shu-Jem Su; Chang-Yu Chen; Kuan-Hua Lin; Miao-Chen Chou; Huey-Wen Shyu
Journal:  Mol Cell Biochem       Date:  2010-06-05       Impact factor: 3.396

3.  Association DENV1 and DENV2 infection with high serum levels of soluble thrombomodulin and VEGF in patients with dengue fever and dengue hemorrhagic fever.

Authors:  Oscar Del Moral-Hernández; Norma E Martínez-Hernández; Manuel A Mosso-Pani; Daniel Hernández-Sotelo; Berenice Illades-Aguiar; Eugenia Flores-Alfaro; Verónica Antonio-Vejar; Marco Antonio Leyva-Vázquez
Journal:  Int J Clin Exp Med       Date:  2014-02-15

Review 4.  Plasma leakage in dengue haemorrhagic fever.

Authors:  Anon Srikiatkhachorn
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

5.  Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model.

Authors:  Vivek V Thacker; Kunal Sharma; Neeraj Dhar; Gian-Filippo Mancini; Jessica Sordet-Dessimoz; John D McKinney
Journal:  EMBO Rep       Date:  2021-05-27       Impact factor: 8.807

Review 6.  Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators.

Authors:  Elzinandes Leal de Azeredo; Robson Q Monteiro; Luzia Maria de-Oliveira Pinto
Journal:  Mediators Inflamm       Date:  2015-04-27       Impact factor: 4.711

7.  Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.

Authors:  Peter Vervaeke; Marijke Alen; Sam Noppen; Dominique Schols; Pasqua Oreste; Sandra Liekens
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 8.  Review: Viral infections and mechanisms of thrombosis and bleeding.

Authors:  M Goeijenbier; M van Wissen; C van de Weg; E Jong; V E A Gerdes; J C M Meijers; D P M Brandjes; E C M van Gorp
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

9.  Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients.

Authors:  Yunus Gurbuz; Baris Ozturk; Emin Ediz Tutuncu; Irfan Sencan; Gonul Cicek Senturk; Fatma Aybala Altay
Journal:  Jundishapur J Microbiol       Date:  2015-10-20       Impact factor: 0.747

Review 10.  The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome.

Authors:  Christina F Spiropoulou; Anon Srikiatkhachorn
Journal:  Virulence       Date:  2013-07-10       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.